Comparing the Roles of Omalizumab and Ultraviolet Therapy in Treating Severe Pediatric Atopic Dermatitis - Reply

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Original language	English
Journal	JAMA Pediatrics
DOIs	https://doi.org/10.1001/jamapediatrics.2020.0969
Publication status	Accepted/In press - 1 Jan 2020

Access to Document

@article{bfb1ac690d4946efa1979be884601afa,

title = "Comparing the Roles of Omalizumab and Ultraviolet Therapy in Treating Severe Pediatric Atopic Dermatitis - Reply",

author = "Susan Chan and Susan Chan and Gideon Lack",

year = "2020",

month = jan,

day = "1",

doi = "10.1001/jamapediatrics.2020.0969",

language = "English",

journal = "JAMA Pediatrics",

issn = "2168-6203",

publisher = "American Medical Association",

}

TY - JOUR

T1 - Comparing the Roles of Omalizumab and Ultraviolet Therapy in Treating Severe Pediatric Atopic Dermatitis - Reply

AU - Chan, Susan

AU - Lack, Gideon

PY - 2020/1/1

Y1 - 2020/1/1

UR - http://www.scopus.com/inward/record.url?scp=85086832840&partnerID=8YFLogxK

U2 - 10.1001/jamapediatrics.2020.0969

DO - 10.1001/jamapediatrics.2020.0969

M3 - Letter

C2 - 32539090

AN - SCOPUS:85086832840

SN - 2168-6203

JO - JAMA Pediatrics

JF - JAMA Pediatrics

ER -